pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›influenza vaccine
drug
save

influenza vaccine

updated 3mo ago
by Curtin University
community read0 votes

🐶 often sniffed alongside

top 4
  • tagVaccine4 co-mentions · 4 sources
  • companyCurtin University1 co-mentions · 1 sources
  • tagCardiology1 co-mentions · 1 sources
  • tagVaccines1 co-mentions · 1 sources

all catalysts(1)

phase 2 completion · 1
Apr 30, 2026
phase 2 completion
4mo ago
Curtin University — influenza vaccine (Phase II Trial Completion)
influenza vaccine
→

Trials studying influenza vaccine

  • phase2A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy Peoplecompletedn=1,353
  • phase2A Study to Investigate the Safety and Immunogenicity of the Quadrivalent Influenza mRNA Vaccines in Adults Aged 18 Years and Abovecompletedn=908
  • phase1Phase I/II Clinical Trial of Influenza Vaccine (Split Virion), Inactivated (High Dose)completedn=50
  • phase3A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults ≥ 50 Years of Ageactive not recruitingn=1,390
  • phase2A Study on the Safety and Immunogenicity of Hexavalent Influenza mRNA Vaccine in Adult Participants 50 Years of Age and Oldercompletedn=1,162
  • phase2Clinical Trials of Quadrivalent Influenza Vaccinerecruitingn=620
  • N/AStructured Review: To Optimise Management and Prevent Harm in COPDrecruitingn=96
  • phase2Clinical Trial to Evaluate the Immunogenicity and Safety of an Adjuvanted A(H1N1)v Influenza Vaccine and a Non-adjuvanted A(H1N1)v Influenza Vaccine in HIV-infected Patients (ANRS 151 Hifluvac)completedn=306
more trials →

News(10)

  • STAT+: Two FDA approvals — a new drug and a new vaccine
    Takeda's narcolepsy drug approved, the first mRNA flu shot approved, and more biotech updates from The Readout
    stat · 13d ago
  • STAT+: Pharmalittle: We’re reading about Moderna’s flu shot, a death in a gene-editing trial in China, and more
    In today's Pharmalittle newsletter: Moderna's mRNA flu shot approved, a death reported in a gene-editing trial in China, and more.
    stat · 13d ago
  • Opinion: One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he was
    “The United States invented this platform and is the only country walking away from it,” Jeff Coller writes of mRNA vaccines.
    stat · 13d ago
  • Covid can reactivate dormant viruses, according to study
    A CDC director officially confirmed, Moderna's mRNA flu shot approved, and other health news from Morning Rounds
    stat · 13d ago
  • FDA approves Moderna’s mRNA flu vaccine, the first to use the technology
    The FDA has approved Moderna’s influenza vaccine, the first licensed flu shot made using messenger RNA technology.
    stat · 14d ago
  • Recon: FDA approves first drug for type 1 narcolepsy, mRNA flu vaccine; No merger talks between AstraZeneca-BMS
    Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.
    raps · 14d ago
  • STAT+: Is there a pharma mega-merger in the making?
    Moderna's imminent FDA vaccine decision, TCGX launches $400M Asia biotech fund, and more biotech news
    stat · 16d ago
  • Half of states sue over Medicaid work requirements
    FDA peptide panelists, a new study on Covid and flu shots, and more health news from Morning Rounds
    stat · 1mo ago
  • Opinion: How to restore credibility to the CDC’s vaccine advisory committee
    Jesse Goodman, former director of CBER and former FDA chief scientist, calls for five critical changes to restore trust in the Advisory Committee on Immunization Practices.
    stat · 3mo ago
  • Opinion: Dropping the flu vaccine requirement puts U.S. military readiness at risk
    Since the 1918 pandemic, the military has acknowledged the threat of influenza. Now that’s changing.
    stat · 3mo ago
view all news mentions →
Data sources
ClinicalTrials.gov
last refreshed 35m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?